You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nep inhibitor

Showing 1 - 25 of 7,380
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Respiratory Distress Syndrome Trial (Racecadotril 100 milligram (MG) Oral Capsule, Placebo)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Racecadotril 100 milligram (MG) Oral Capsule
  • Placebo
  • (no location specified)
Jan 13, 2023

Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)

Recruiting
  • Heart Failure
  • LCZ 696
  • +4 more
  • New Haven, Connecticut
    Yale New Haven Hospital
Dec 27, 2022

Heart Failure Trial in Cairo (myocardial function after surgery)

Recruiting
  • Heart Failure
  • myocardial function after surgery
  • Cairo, Egypt
  • +1 more
Oct 13, 2023

Brain Activity Patterns in Persons With Spinal Cord Injury and

Recruiting
  • Spinal Cord Injuries
  • Neuropathic Pain
    • Nottwil, Lucerne, Switzerland
      Swiss Paraplegic Centre; Centre for pain medicine
    Oct 31, 2022

    Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,

    Completed
    • Idiopathic Membranous Nephropathy
    • symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
    • experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
    • Paris, France
      Department of Nephrology , Tenon hospital - APHP
    Oct 18, 2021

    Heart Failure With Preserved Ejection Fraction Trial in Rochester (Entresto™ 49Mg-51 mg tablet)

    Completed
    Has Results
    • Heart Failure With Preserved Ejection Fraction
    • Entresto™ 49Mg-51 mg tablet
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2022

    Thyroid Cancer, Medullary Trial in Basel (177Lu-PP-F11N, Sacuitril)

    Completed
    • Thyroid Cancer, Medullary
    • Basel, Switzerland
      University Hospital Basel, Clinic for radiology and nuclear medi
    Feb 9, 2022

    Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing/China, China
    • +1 more
    Oct 9, 2023

    Intravenous Drug Abuse, S Aureus Colonization Trial (Chlorhexidine Topical)

    Completed
    • Intravenous Drug Abuse, S Aureus Colonization
    • Chlorhexidine Topical
    • (no location specified)
    Apr 21, 2022

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Type2 Diabetes Trial in Hvidovre (Entresto, Sitagliptin, Valsartan)

    Completed
    • Type2 Diabetes
    • Hvidovre, RegionH, Denmark
      Hvidovre Hospital
    May 4, 2021

    Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

    Not yet recruiting
    • Cervical Cancer
    • Anti-PD-1 antibody balstilimab
    • Amsterdam, Netherlands
      Amsterdam UMC
    Oct 17, 2023

    Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

    Recruiting
    • Hepatocellular Carcinoma (HCC)
    • Kaohsiung, Taiwan
    • +4 more
    Mar 14, 2023

    Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

    Not yet recruiting
    • Chronic Kidney Disease
    • Part A - Lorundrostat QD + Dapaglifozin QD
    • +2 more
    • (no location specified)
    Nov 27, 2023

    HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

    Not yet recruiting
    • HIV Infections
    • Las Vegas, Nevada
    • +1 more
    Aug 21, 2023

    Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • (no location specified)
    Aug 31, 2023

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

    Not yet recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Aug 23, 2023

    Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • Pavia, Lombardia, Italy
      Istituti Clinici Scientifici Maugeri
    May 5, 2023

    Blood Vessel Function in Postmenopausal Women With Breast Cancer

    Active, not recruiting
    • Breast Cancer
    • Rochester, Minnesota
      Mayo Clinic
    Jan 17, 2023

    Healthy Trial in Biberach (BI 1810631, Itraconazole)

    Recruiting
    • Healthy
    • Biberach, Germany
      Humanpharmakologisches Zentrum Biberach
    Apr 27, 2023

    Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

    Not yet recruiting
    • Adenoid Cystic Carcinoma
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 14, 2023

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Tegoprazan, Esomeprazole)

    Active, not recruiting
    • Vonoprazan
    • +2 more
    • Hangzhou, Zhejiang, China
      Hangzhou first people's Hospital
    Dec 2, 2022

    Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)

    Recruiting
    • Breast Cancer
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
    Nov 20, 2023

    Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

    Recruiting
    • Her-2 Negative Breast Cancer
    • HRR Gene Mutation
    • Guangzhou, Guangdong, China
      First Affiliated Hospital, Sun Yat-Sen University
    Mar 7, 2023